Healthcare in Saudi Arabia / NEOM
Pharmaceutical platforms in Saudi Arabia / NEOM expanding to new markets encounter FDA, EMA, and regional regulatory frameworks that require architectural changes to clinical data handling and audit trail infrastructure. UAE PDPL and DIFC compliance posture requires jurisdiction-specific adaptation.
Pharmaceutical technology lives under FDA 21 CFR Part 11. Data integrity isn't optional — it's existential. Clinical trial data, manufacturing execution, regulatory submissions — every system requires validated, compliant infrastructure.
How We Deliver in Saudi Arabia / NEOM
UAE & Gulf and Healthcare Frameworks
Healthcare organizations in Saudi Arabia / NEOM operate under both UAE & Gulf regional frameworks and sector-specific compliance requirements. We embed all applicable frameworks architecturally — not as a parallel compliance workstream running alongside engineering.